Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-09-27
2005-09-27
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
06949509
ABSTRACT:
Pharmaceutical compositions containing a small or medium size peptide, free from preservatives and stable before and during the use.
REFERENCES:
patent: 4853375 (1989-08-01), Krupin et al.
patent: 5482931 (1996-01-01), Harris et al.
patent: 5763398 (1998-06-01), Bengtsson
patent: 5783559 (1998-07-01), Florin-Robertsson et al.
patent: WO9501183 (1995-01-01), None
Fredholt et. al. Alpha-chymotrypsin-catalyzed degradation of desmopressin (dDAVP): influence of pH, concentration and various cyclodextrins. Int J Pharm Feb. 15, 1999; 178(2): 223-9.
“Martindale's Complete Drug Reference”,Pharmaceutical Press, 1999, pp. 735-736.
Clayton Petty M.D., and Nelson L. Cunningham, M.D., “Insulin Adsorption by Glass Infusion Bottles, Polyvinylchloride Infusion Containers, and Intravenous Tubing”,Anesthesiology, vol. 40, No. 4, (1974).
A.T. Florence and D. Attwood,Physicochemical Principles of Pharmacy, Third Edition, pp. 328-331, (1999).
Abelman ,Frayne & Schwab
Audet Maury
Patents Exploitation Company B.V.
Tate Christopher R.
LandOfFree
Pharmaceutical composition containing a small or medium size... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing a small or medium size..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing a small or medium size... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3397275